4 5 Advanced Skin Cheltenham Ltd 13129128 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is that of advanced skincare procedures Digita Accounts Production Advanced 6.30.9574.0 true 13129128 2023-02-01 2024-01-31 13129128 2024-01-31 13129128 bus:Director1 1 2024-01-31 13129128 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-01-31 13129128 core:CurrentFinancialInstruments 2024-01-31 13129128 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 13129128 core:FurnitureFittingsToolsEquipment 2024-01-31 13129128 core:OtherPropertyPlantEquipment 2024-01-31 13129128 bus:SmallEntities 2023-02-01 2024-01-31 13129128 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13129128 bus:FilletedAccounts 2023-02-01 2024-01-31 13129128 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 13129128 bus:Director1 2023-02-01 2024-01-31 13129128 bus:Director1 1 2023-02-01 2024-01-31 13129128 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-02-01 2024-01-31 13129128 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13129128 core:FurnitureFittings 2023-02-01 2024-01-31 13129128 core:FurnitureFittingsToolsEquipment 2023-02-01 2024-01-31 13129128 core:OfficeEquipment 2023-02-01 2024-01-31 13129128 core:OtherPropertyPlantEquipment 2023-02-01 2024-01-31 13129128 countries:EnglandWales 2023-02-01 2024-01-31 13129128 2023-01-31 13129128 bus:Director1 1 2023-01-31 13129128 core:FurnitureFittingsToolsEquipment 2023-01-31 13129128 core:OtherPropertyPlantEquipment 2023-01-31 13129128 2022-02-01 2023-01-31 13129128 2023-01-31 13129128 bus:Director1 1 2023-01-31 13129128 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-01-31 13129128 core:CurrentFinancialInstruments 2023-01-31 13129128 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 13129128 core:FurnitureFittingsToolsEquipment 2023-01-31 13129128 core:OtherPropertyPlantEquipment 2023-01-31 13129128 bus:Director1 1 2022-02-01 2023-01-31 13129128 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-02-01 2023-01-31 13129128 bus:Director1 1 2022-01-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 13129128

Advanced Skin Cheltenham Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 January 2024

 

Advanced Skin Cheltenham Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 8

 

Advanced Skin Cheltenham Ltd

(Registration number: 13129128)
Abridged Balance Sheet as at 31 January 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

3

2,668

1,141

Current assets

 

Stocks

4

6,000

5,000

Debtors

5

7,092

10,197

Cash at bank and in hand

 

4,532

3,110

 

17,624

18,307

Creditors: Amounts falling due within one year

(18,832)

(18,330)

Net current liabilities

 

(1,208)

(23)

Total assets less current liabilities

 

1,460

1,118

Provisions for liabilities

(682)

(373)

Accruals and deferred income

 

(720)

(720)

Net assets

 

58

25

Capital and reserves

 

Called up share capital

6

1

1

Retained earnings

57

24

Shareholders' funds

 

58

25

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 29 January 2025
 

.........................................
Mrs Amber Danson
Director

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

1

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

25% Reducing balance method

Office equipment

33% Straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 4 (2023 - 5).

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

3

Tangible assets

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 February 2023

2,626

100

2,726

Additions

-

2,834

2,834

At 31 January 2024

2,626

2,934

5,560

Depreciation

At 1 February 2023

1,565

20

1,585

Charge for the year

724

583

1,307

At 31 January 2024

2,289

603

2,892

Carrying amount

At 31 January 2024

337

2,331

2,668

At 31 January 2023

1,061

80

1,141

4

Stocks

2024
£

2023
£

Other inventories

6,000

5,000

5

Debtors

Debtors includes £Nil (2023 - £Nil) due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

1

1

1

1

       

7

Dividends

Interim dividends paid

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

2024
£

2023
£

Interim dividend of £23,700.00 (2023 - £1,000.00) per each Ordinary shares

23,700

1,000

 

 

Interim dividends paid

2024
£

2023
£

Interim dividend of £23,700 (2023 - £1,000) per each Ordinary shares

23,700

1,000

 

 

8

Related party transactions

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Transactions with the director

2024

At 1 February 2023
£

Advances to director
£

Other payments made to company by director
£

At 31 January 2024
£

Mrs Amber Danson

Directors loan account

8,480

47,220

(52,127)

3,573

2023

At 1 February 2022
£

Advances to director
£

Other payments made to company by director
£

At 31 January 2023
£

Mrs Amber Danson

Directors loan account

3,081

34,938

(29,539)

8,480

 

Advanced Skin Cheltenham Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Director's remuneration

The director's remuneration for the year was as follows:

2024
£

2023
£

Remuneration

15,167

23,750

Contributions paid to money purchase schemes

1,061

1,662

16,228

25,412